Bonus BioGroup Ltd. (TLV:BONS)
Israel · Delayed Price · Currency is ILS · Price in ILA 43.50
-0.80 (-1.81%)
At close: Feb 27, 2026
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 508.05 million as of February 27, 2026. Its market cap has increased by 121.94% in one year.
Market Cap
508.05M
Enterprise Value
516.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
43.50
Market Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 508.05M, an increase of 4,009.55%. That is a compound annual growth rate of 31.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 508.05M | 73.31% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 259.73M |
| Matricelf | 145.43M |
| Clal Biotechnology Industries | 45.96M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 30.81M |
| Evogene | 22.88M |
| XTL Biopharmaceuticals | 20.82M |
| Purple Biotech | 18.58M |